|
Volumn 26, Issue 1, 2005, Pages 33-40
|
Combination of vitamin K2 plus imatinib mesylate enhances induction of apoptosis in small cell lung cancer cell lines.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
FARNOQUINONE;
IMATINIB;
PIPERAZINE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PROTEIN TYROSINE KINASE;
PYRIMIDINE DERIVATIVE;
STEM CELL FACTOR;
APOPTOSIS;
ARTICLE;
CELL PROLIFERATION;
DRUG ANTAGONISM;
DRUG COMBINATION;
DRUG EFFECT;
HUMAN;
IC 50;
LUNG TUMOR;
METABOLISM;
PHOSPHORYLATION;
SMALL CELL CARCINOMA;
TUMOR CELL LINE;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CARCINOMA, SMALL CELL;
CELL LINE, TUMOR;
CELL PROLIFERATION;
DRUG COMBINATIONS;
HUMANS;
INHIBITORY CONCENTRATION 50;
LUNG NEOPLASMS;
PHOSPHORYLATION;
PIPERAZINES;
PROTEIN KINASE INHIBITORS;
PROTEIN-TYROSINE KINASES;
PYRIMIDINES;
STEM CELL FACTOR;
VITAMIN K 2;
MLCS;
MLOWN;
|
EID: 21644456378
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.26.1.33 Document Type: Article |
Times cited : (23)
|
References (0)
|